TART - Troglitazone Atherosclerosis Regression Trial

Clinical trial NCT00116545 · COMPLETED

Trial details

NCT number: NCT00116545
Sponsor: Parke-Davis
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Atherosclerosis Diabetes Mellitus

Start date: 1997-01-01
Primary completion: 2000-04-01
Enrollment: 288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.